You are here

TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration, announced today that it will report its fourth quarter and full year 2018 financial and operating results after the close of U.S. financial markets on Thursday, February 28, 2019. In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.
Thursday, February 21, 2019 - 16:03